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Abstract
Background: microRNAs (miRNAs) play an essential role in the post-transcriptional gene regulation in plants and
animals. They regulate a wide range of biological processes by targeting messenger RNAs (mRNAs). Evidence
suggests that miRNAs and mRNAs interact collectively in gene regulatory networks. The collective relationships
between groups of miRNAs and groups of mRNAs may be more readily interpreted than those between individual
miRNAs and mRNAs, and thus are useful for gaining insight into gene regulation and cell functions. Several
computational approaches have been developed to discover miRNA-mRNA regulatory modules (MMRMs) with a
common aim to elucidate miRNA-mRNA regulatory relationships. However, most existing methods do not consider
the collective relationships between a group of miRNAs and the group of targeted mRNAs in the process of
discovering MMRMs. Our aim is to develop a framework to discover MMRMs and reveal miRNA-mRNA regulatory
relationships from the heterogeneous expression data based on the collective relationships.
Results: We propose DIscovering COllective group RElationships (DICORE), an effective computational framework for
revealing miRNA-mRNA regulatory relationships. We utilize the notation of collective group relationships to build the
computational framework. The method computes the collaboration scores of the miRNAs and mRNAs on the basis of
their interactions with mRNAs and miRNAs, respectively. Then it determines the groups of miRNAs and groups of
mRNAs separately based on their respective collaboration scores. Next, it calculates the strength of the collective
relationship between each pair of miRNA group and mRNA group using canonical correlation analysis, and the group
pairs with significant canonical correlations are considered as the MMRMs. We applied this method to three gene
expression datasets, and validated the computational discoveries.
Conclusions: Analysis of the results demonstrates that a large portion of the regulatory relationships discovered by
DICORE is consistent with the experimentally confirmed databases. Furthermore, it is observed that the top mRNAs
that are regulated by the miRNAs in the identified MMRMs are highly relevant to the biological conditions of the given
datasets. It is also shown that the MMRMs identified by DICORE are more biologically significant and functionally
enriched.
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Background
microRNAs (miRNAs) are a family of small (i.e. with typi-
cal length of 19–25 nucleotides) non-protein-coding RNA
molecules that can play important regulatory roles in ani-
mals and plants [1, 2]. They base-pair with messenger
RNAs (mRNAs) of protein-coding genes to induce mRNA
degradation or translational repression [3]. The mature
human miRNAs potentially target majority of the human
mRNAs [4]. It has been demonstrated that miRNAs reg-
ulate a wide range of biological or cellular processes such
as proliferation [5, 6], metabolism [7], differentiation [8],
development [9], apoptosis [10], cellular signaling [11],
and cancer development and progression [12–15].
There is a growing body of literature showing that mul-
tiple miRNAs are coordinated by forming cohesive groups
to collectively regulate one or more pathways [16, 17].
The collective relationships yielded between a group of
miRNAs and a group of mRNAs due to the tendency
of the group formation act as a vital force in cater-
ing similar functioning miRNAs and mRNAs together.
Therefore, the collective relationships between cohesive
groups of miRNAs and their targeted mRNAs may pro-
vide better understandings on robust and potent regula-
tory relationships of miRNA-mRNA regulatory modules
(MMRMs).
Several algorithms have been proposed to identify
MMRMs from expression data using different approaches
including Bayesian network learning [18], rule induc-
tion [19], association rule mining [20], population-based
probabilistic learning [21], probabilistic graphical model
[22–24], matrix factorization [25], and graph mining
[17, 26]. Most of these existing methods do not consider
the collective relationships between a group of miRNAs
and the group of targeted mRNAs in the process of iden-
tifying MMRMs. In addition, many of them are either
stochastic, or require prior knowledge such as number of
modules to be identified, confirmed interactions, target
site information [27].
Adapting a greedy overlapping neighborhood expansion
clustering method, ClusterONE, which was developed to
discover protein complexes from protein-protein inter-
actions networks, Li et al. [27] proposed a clustering
algorithm, Mirsynergy to detect synergistic miRNA reg-
ulatory modules. However, it requires and depends on
the prior knowledge of confirmed gene-gene interactions.
Recently Karim et al. [28] coined the notion of collective
group relationships, and developed a method by integrat-
ing unweighted graphing mining concept and canonical
correlation analysis to explore miRNA-mRNA regula-
tory relationships. However, it is noted that unweighted
graph mining techniques are associated with limitation
in representing the true interactions, and sometimes
fail to capture correct regulatory relationships. Whereas
weighted graph mining approaches can greatly improve
the detection of the module structures [29], and hence
regulatory relationships.
In this paper, we propose an effective computational
framework, DIscovering COllective group RElationships
(DICORE) to identify MMRMs and hence reveal miRNA-
mRNA regulatory relationships from heterogeneous data.
In order to extract MMRMs from the given gene expres-
sion datasets, we utilize the notion of collective group
relationships, which provide MMRMs with additional
quantitative strength information. The method finds a
deterministic solution to the problem of discovering
MMRMs from weighted bipartite graph representation of
the given datasets, and rank the collective group relation-
ships based on their strength of collective relationships.
We applyDICORE to a dataset for Epithelial toMesenchy-
mal Transition, a breast cancer dataset, and a multi-class
cancer dataset. Based on the knowledge from the liter-
ature, it is observed that the identified MMRMs exhibit
enriched functionality with biological significance.
Methods
Problem statement
Consider two sets of variables X = {X1, . . . ,Xp} and
Y = {Y1, . . . ,Yq} such that X ∩ Y = ∅, represent-
ing the attributes of two different types of objects. In
this paper, X and Y refer to the expression levels of a
set of miRNAs and a set of mRNAs, respectively. With
their given datasets, DX and DY, having n matching
miRNA and mRNA expression samples, our goal is to
identify any Cx ⊂ X and Cy ⊂ Y, such that Cx and
Cy are related, as a result of miRNAs in Cx collabora-
tively interacting with mRNAs in Cy and vice versa. We
call (Cx,Cy) a group pair, and the relationship between
Cx and Cy a COllective group RElationship (in short,
CORE). The COREs are characterized by both group pairs
and the collective relationships among the two cohesive
groups in group pairs. Then the group pair (Cx,Cy) is an
MMRM if the strength of the CORE between Cx and Cy is
significant.
In order to discover COREs, and thus to identify
MMRMs, we develop a two stages method, DIscov-
ering CORE (DICORE). Two measures, collaboration
score and canonical correlations, are employed in the
two stages respectively. In the following, we firstly
overview the workflow of DICORE, and then present
the details of DICORE, including the definition of the
collaboration score and the calculation of canonical
correlations.
Overview of DICORE
Figure 1 shows the workflow of DICORE. The overall
workflow comprises a data pre-processing step and two
main stages: (1) forming separate miRNA and mRNA
groups and (2) searching for COREs.
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Fig. 1 DICORE workflow. Given the inputs of miRNA and mRNA expression profiles, we first derive an expression-based interaction weights matrixW
using correlation test. We then compute two collaboration score matrices S and T fromW for miRNAs and mRNAs based on their functional
interaction similarities with common mRNAs (or miRNAs), respectively. Using these collaboration scores as input, we separately generate groups of
miRNAs and groups of mRNAs at Stage 1 by an overlapping neighborhood expansion clustering algorithm, in which miRNAs or mRNAs are greedily
added to (removed from) each cluster of miRNAs or mRNAs, respectively that maximize cohesiveness score of the cluster. Next in Stage 2, we apply
canonical correlation analysis on the groups of miRNAs and groups of mRNAs to obtain significant collective group relationships, which are
eventually the MMRMs with strength scores
In the data pre-processing step, DICORE first creates
a weighted bipartite graph representation of the relation-
ships among the individual variables of the given miRNA
and mRNA expression profiles. Taking the variables as
the vertices of a weighted bipartite graph G, a weighted
edge is introduced between a miRNA variable and a
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mRNA variable to represent their interaction. Referring
to Fig. 1, given p miRNAs and q mRNAs, let W denote
the (p × q) miRNA-mRNA interaction weights matrix,
where wij is the interaction weight for miRNA i tar-
geting mRNA j. To compute miRNA-mRNA interaction
weights, we calculate the Pearson correlation coefficient
(PCC) [25] between each pair of miRNA and mRNA
using the R built-in function, cor. The obtained PCCs are
within the range of [−1, 1], and the signed correlation
coefficients provide two types of valuable information:
the absolute values implying the strength of the miRNA-
mRNA interactions (the higher the values, the stronger
the interactions), and the signs indicating the directions
of the associations. However, as the aim of the paper
is to identify MMRMs (and thus to uncover miRNA-
mRNA regulatory relationships), the collaboration score
(explained in the next section) defined for discovering the
modules considers the sum of the miRNA-mRNA corre-
lations. In order to cater for both up and down miRNA
regulations when calculating the total strength of the
interactions, we use absolute values of the PCCs in the
interaction weights matrixW, otherwise the signed PCCs
or interaction weights will cancel out in Eq. (1).
Due to the higher possibility of dense interactions in
the expression profile datasets, complete weighted graph
miningmay not be able to distinguish correct group struc-
ture. Accordingly we used a cutoff threshold η to trade
off between the two extreme approaches namely complete
unweighted graph mining and complete weighted graph
mining.
At stage 1, we separately identify groups of miR-
NAs and groups of mRNAs. Referring to Fig. 1, based
on the interaction weights matrix W, we firstly calcu-
late the collaboration score between each pair of miR-
NAs and create the miRNA-miRNA collaboration matrix,
S. The collaboration score between a pair of miRNAs
reflects their similarity or collaboration in regulating tar-
get mRNAs (more details of collaboration scores are
given in the next section). In a similar way, we com-
pute the collaboration score between each pair of mRNAs
(which implies their similarity in being regulated by
miRNAs) and create the mRNA-mRNA collaboration
matrix, T.
The identification of groups of miRNAs (or groups of
mRNAs) is formulated as an overlapping clustering prob-
lem. Only the miRNAs (or mRNAs) that have strong
collaboration between them are put in the same group,
i.e. we use their collaboration scores as the similarity mea-
sure for the clustering. The clustering process is then
aimed at maximizing the overall similarity of the miR-
NAs (or mRNAs) within the same group. We define such
overall similarity within a group as the cohesiveness of
a group (details of the definition is provided in the next
section). The underlying clustering algorithm adapts from
ClusterONE, which was originally developed for protein
protein interaction networks [29]. Adopting the idea from
[25], we discard groups with fewer than 5 mRNAs (i.e.
minimum size threshold for mRNAs, θg = 5), as they
usually do not provide relevant information. Similarly, we
are not interested to consider groups having more than
500 mRNAs. Additionally, in order to avoid ‘star-shaped’
basic network structure, we choose 3 as minimum size
threshold for miRNAs, θm.
At stage 2, we use canonical correlation analysis to com-
pute the strength of the collective relationships between
groups of miRNAs and groups of mRNAs in terms
of canonical correlations, and obtain COREs, which is
eventually equivalent to MMRMs with additional quan-
titative information. We considered only the top COREs
identified (i.e. the COREs with the higher canonical
correlations), having minimum canonical correlation of
ρ = 0.50.
Details of DICORE
In the following, we introduce the details of the collabora-
tion score and how CCA is used to measure the strength
of the collective group relationships.
The collaboration score expresses the degree of collab-
oration between two miRNAs (or between two mRNAs)
considering their common interactions with mRNAs (or
miRNAs). Given miRNA i, miRNA j (6= i) and the interac-
tion weights matrix W, the collaboration score of the two














where l is the number of other possible components that
both miRNA i and miRNA j interact with, in this case
mRNAs, so l = q. Let S refer to the miRNA-miRNA
collaboration matrix of size p× p, where sij = vij.
Similarly, we compute the mRNA-mRNA collaboration
score between mRNA i and mRNA j (6= i) by applying
Eq. (1) on the transpose of the interaction weights matrix
W, where l = p, the number of miRNAs. Let T refer to the
mRNA-mRNA collaboration matrix of size q × q, where
tij = vij.
Notably, if W were a binary matrix, Eq. (1) became the
ratio of number of target mRNAs shared between miRNA
i and miRNA j over the numbers of target mRNAs pos-
sessed separately by miRNA i or miRNA j (or the ratio
of number of common miRNAs regulate both mRNA
i and mRNA j over the numbers of miRNAs individu-
ally regulate mRNA i or mRNA j). An miRNA (or an
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Using collaboration scores as the similarity measures
of pairs of miRNAs or pairs of mRNAs, miRNAs and
mRNAs are clustered separately into cohesive groups by
using a greedy strategy that maximize the cohesiveness
score of groups. Similar to the cohesiveness defined in
[29], we define cohesiveness score, cs(Ci) for any group Ci
as follows:
cs(Ci) = wint(Ci)
wint(Ci)+ wext(Ci)+ α ∗ |Ci| (2)
wherewint(Ci) denotes the sum of the collaboration scores
of all the internal pairs of variables, i.e. each pair only con-
tains variables within the group Ci; wext(Ci) is the sum of
the collaboration scores of all the external pairs, i.e. each
pair contains one variable within the group Ci and one
variable outside the group Ci; and α∗|Ci| is a penalty term
asserting the existence of unidentified interactions in the
dataset, practically assuming that every component in Ci
has α additional interactions that are undetected due to
the limitations in the experimental setting.
DICORE uses canonical correlation analysis (CCA) [30]
to compute the strength of the collective relationships
between a group of miRNAs and a group of mRNAs in
terms of the group pair’s canonical correlations. CCA
is commonly used for quantifying the linear association
between two sets of variables. Consider A = Ea′ EX, B =
Eb′ EY be the corresponding linear combinations of sets of
variables EX and EY respectively, where Ea and Eb are coef-
ficient vectors. Vectors Ea and Eb are chosen such that the
correlation betweenA and B, i.e.,






is maximized, where 6XX , 6YY and 6XY are variance
of EX, variance of EY , and covariance between EX and EY ,
respectively. The correlation r between the pair of lin-
ear combinations in Eq. (3) is called canonical correlation.
Specifically, canonical correlation between a group of
miRNAs and a group of mRNAs is computed using the R
function CCA from the package PMA.
The intuition behind applying CCA is twofold. Firstly
CCA captures weight scores of all interactions between all
miRNAs andmRNAs in both groups of a group pair, while
computing the strength of the collective interactions of
the group pair. As a consequence, CCA mitigates the loss
of weight scores of interactions due to the application of
cutoff threshold η earlier. Secondly, it also makes it possi-
ble for a group of miRNAs (or a group of mRNAs) to be
included in more than one CORE i.e. one module, if the
strength of collective interactions satisfies the specified
threshold.
Data collection
Three real-world gene expression datasets are used to
validate DICORE: an NCI60 dataset for Epithelial to Mes-
enchymal Transition, a breast-cancer (BR) dataset, and
a multi-class cancer (MCC) dataset. The pre-processed
differentially expressed gene expression datasets were col-
lected from [31].
Epithelial to Mesenchymal Transition (EMT) is a bio-
logical process that enables cells to acquire migratory
mesenchymal characteristics by losing epithelial features.
The EMTs are associated with embryonic development,
wound healing, organ fibrosis, and in the initiation of
metastasis for cancer progression. The NCI60 dataset
includes 60 cancer cell lines from the National Cancer
Institute (NCI). Cell lines categorized as epithelial (11
samples) and mesenchymal (36 samples) were used for
this work. As a result of the differential gene expression
analysis, 1154 mRNAs and 35 miRNAs were identified
to be differentially expressed at significant level (adjusted
p-value < 0.05, adjusted by Benjamini-Hochberg (BH)
method).
The BR dataset includes expression profiles of the 50
cell lines of breast cancer. The cell lines were categorized
as luminal (27 cell lines) and basal (23 cell lines). In the
dataset, 89 miRNAs (adjusted p-value < 0.02) and 1500
mRNAs (adjusted p-value < 0.0001) were identified to be
differentially expressed.
The MCC dataset includes samples from multiple can-
cers namely bladder, breast, colon, kidney, lung, pancreas,
prostate and uterus. Samples of the dataset classified as
normal (21 samples) and tumor (67 samples) were used
in this work. In total, 62 miRNAs and 1318 mRNAs were
obtained to be differentially expressed at significant level
(adjusted p-value < 0.05).
The datasets are available in Additional file 1.
We used the expression data to calculate the miRNA-
mRNA interaction weights matrix W. We obtained the
interaction weights of W by computing the absolute val-
ues of the Pearson correlation coefficients between pairs
of miRNA and mRNA.
In order to obtain the ‘ground-truth’ databases of experi-
mentally confirmedmiRNA-mRNA interactions, we com-
bined the interactions from four popular interactions
databases, namely DIANA-TarBase v7.0 [32], miRTarBase
v4.5 [33], miRecords v2013 [34], and miRWalk v2.0 [35].
While miRWalk contains both predicted and experimen-
tally validated miRNA-mRNA interactions, rest of the
databases include high quality manually curated experi-
mentally validated miRNA-mRNA interactions published
in the literature. Recently published DIANA-TarBase v7.0
alone included more than half a million interactions
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utilizing cell types from 24 species. We also added a
HITS-CLIP database [36], which lists the confirmed tar-
gets of two miRNAs, namely miR-200a and miR-200b.
We extracted only the confirmed miRNA-mRNA inter-
actions associated with the human miRNAs and mRNAs
given in the input datasets, and removed the duplicate
entries. Finally, we obtained ‘ground-truth’ databases of
2147, 5791, and 8733 unique miRNA-mRNA interactions
for the 29 miRNAs in the NCI60 dataset (there are no
confirmed interactions for the 6 miRNAs with the name
prefix hsa-miRPlus-), 89 miRNAs in the BR dataset, and
62 miRNAs in the MCC dataset, respectively. Details of
the ‘ground-truth’ databases are available in Additional
file 2.
Results and discussions
We ran the experiment for all values for the cutoff thresh-
old η in the range from 0 to 1 with a step size of 0.05.
We only reported the summary and top results for each
dataset. In each summary table, #C, mR, miR, r¯, and t
denote the number of COREs identified, average num-
ber of mRNAs in COREs, average number of miRNAs in
COREs, average strength of the COREs, and time taken
for the execution in seconds, respectively. The group dis-
tributions and all COREs for all datasets are described in
details on our website (visit [37]).
The NCI60 Dataset
The results obtained from the NCI60 dataset are sum-
marized in Table 1. It is clear from the summary that
potentially interesting results are obtained for the η val-
ues ranging from 0.60 to 0.85. By lowering the values of η,
more miRNAs and mRNAs were added to these groups.
For more in-depth analysis, we look more closely at some
of the particular results.
We obtained the most informative result (in terms of
the strength of COREs, and number of experimentally
confirmed interactions covered) for η = 0.60, with 8
COREs involving 1 miRNA groups and 8 mRNA groups.
Table 1 Summary of results of DICORE on the NCI60 dataset
η #C mR miR r¯ t
0.45 1 6.00 35.00 0.61 1142.88
0.50 4 8.50 32.00 0.64 635.31
0.55 3 11.67 27.00 0.69 246.17
0.60 8 57.00 19.00 0.80 80.89
0.65 6 83.67 10.50 0.79 86.95
0.70 4 107.50 6.25 0.81 24.30
0.75 4 44.00 5.00 0.87 4.78
0.80 2 22.50 5.00 0.91 2.44
0.85 1 12.00 5.00 0.95 0.90
Table 2 Summary of results of DICORE on the BR dataset
η #C mR miR r¯ t
0.50 3 8.00 15.00 0.66 1938.13
0.55 44 23.57 6.18 0.63 2043.01
0.60 33 48.09 6.61 0.70 216.53
0.65 24 47.79 3.00 0.69 36.49
The only group of miRNAs ‘m1N60’ catered in total
19 miRNAs including the miR-200 family. On the other
hand, we got the top mRNAs group (group having high-
est cohesiveness) ‘g1N60’ having 348 mRNAs. It included
CDH1 (epithelial cadherin or in short E-cadherin, a clas-
sical member of the cadherin superfamily, which plays a
vital role in EMT such that EMT is also characterized by
repression of E-cadherin expression), ZEB1 (E-cadherin
transcriptional repressor, which is usually targeted by
miR-200 family), and TWIST1 (one of the important EMT
inducers).
Furthermore, another interesting result was obtained
for η = 0.65. We got 6 COREs from 2 groups of miRNAs
and 3 groups of mRNAs. The top miRNAs group ‘m1N65’
catered 14 miRNAs and is a proper subset of ‘m1N60’. The
second miRNAs group ‘m2N65’ included total 7 miRNAs
including 3miRNAs from themiR-17 miRNA gene family,
namelymiR-106b,miR-18a, andmiR-18b.
The BR dataset
From the summary given in Table 2, it is seen that higher
informative results were obtained for η values from 0.55 to
0.65 from the BR dataset. The most informative result was
obtained for η = 0.60. We got 33 COREs from 2 groups
of miRNAs and 17 groups of mRNAs. The top group of
miRNAs included miR-221 and miR-222, both of them
are known to play important regulation role in aggressive
breast cancer [38].
The MCC dataset
Table 3 shows the results obtained by DICORE on the
MCC dataset. The most informative result is obtained for
η = 0.45. It catered all members of both let-7 andmiR-30
miRNA gene families into the top group of miRNAs along
with some other similar functioning miRNAs.
Table 3 Summary of results of DICORE on the MCC dataset
η #C mR miR r¯ t
0.40 7 15.71 35.00 0.58 354.30
0.45 10 84.70 20.40 0.58 540.36
0.50 5 30.40 29.00 0.72 12.40
0.55 1 55.00 25.00 0.80 4.18
0.60 1 19.00 9.00 0.82 1.45
Karim et al. BMC Genomics 2015, 17(Suppl 1):7 Page 77 of 192
Table 4 Confirmed interactions in COREs from the NCI60 for
η = 0.65
ID Confirmed interactions
C1N65 miR-141: BICD2, CDH1, EHF, IRF6, KLF5,
PARD6B, RAB32, RAB8B, RHOD, SLC20A1,
TWIST1;
miR-148b: BIK, DDR1, ELOVL5, ERMP1, FAM84B,
KLF5, MAL2, MAP1B, QKI, RAB8B, ST14,
TBC1D30, TRAF4;
miR-200a: BICD2, CDH1, EHF, ELOVL5, GRHL2,
ITGB4, MAP1B, MSN, PARD6B, RAB32, TWIST1;
miR-200b: AP1S2, ARHGAP32, CDH1, CLDN4, DSP,
ELOVL5, ENSA, EPCAM, ESRP2, KIAA1949, KLF5,
MAL2, MAP1B, MAPK13, MSN, OSTM1, PARD6B,
QKI, SACS, SLC20A1, TINAGL1, TTL, TWIST1;
miR-200c: AP1S2, CDH1, ENSA, ICA1, MSN,
OSTM1, PARD6B, QKI, SLC20A1, ST14, TPD52L1,
TWIST1, VIM;
miR-203: ARHGAP32, CDH1, ENSA, FAM84B,
OVOL1, PARD6B, TC2N, TPD52L1, VIM;
miR-301a: AP1S2, BICD2, ERMP1, ESRP2, IRF6,
MAL2, MAP1B, MAP7, PRRG4, SLC20A1, TRAF4,
TTL, TWIST1;
miR-301b: AP1S2, BICD2, MAP1B, PRRG4, TRAF4,
TTL;
miR-32: BICD2, QKI, RAB8B, RBM47, RNF43,
SACS, TWIST1, VIM;
miR-429: GRHL1, QKI, TWIST1;
miR-590-3p: CDS1, DSP, ELOVL5, MAP1B, MRPL49,
PARD6B, RAB8B, RBM47, SACS, SLC20A1;
miR-7: ARHGAP32, DSC2, DSP, EPN3, ESRP1,
F11R, FAM83H, FAM84B, GRHL1, GSR, LPAR2,
MAP1B, MYO5B, PARD6B, PLS1, QKI, RAB11FIP4,
S100A14, SACS, SLC29A2, TRAF4;
C2N65 miR-141: TMC5;
miR-148b: EFNA1, MUC13, TBC1D30, TSKU;
miR-200a: PLEKHF2, TMC5, TSKU;
miR-200b: EFNA1, TACSTD2;
miR-200c: EFNA1; miR-301a: PLEKHF2, TSKU;
miR-301b: PLEKHF2; miR-32: PALM2-AKAP2;
miR-429: EFNA1; miR-7: ANGEL1, LPAR2, TSKU;
C3N65 miR-101: AP1S2, BICD2, CLDN4, DLG3, MSN,
RAB8B, SACS, SLC29A2, TST;
miR-106b: BICD2, BMP4, DSP, ESRP1, F11R,
GIPC2, KIAA1522, MAP7, MCF2L, MPZL2, MYO5B,
OSTM1, PARD6B, PLS1, RAB8B, RBM47, S100P,
Table 4 Confirmed interactions in COREs from the NCI60 for
η = 0.65 (Continued)
SACS, SLC29A2, TBC1D30
miR-18a: BICD2, BMP4, ELOVL5, ESRP1, INADL,
MAP1B, MARK2, PARD6B;
miR-18b: BICD2, ESRP1, INADL, MAP1B, SCNN1A;
miR-30e: ABHD11, ANPEP, DSP, ELOVL5, FAM84B,
GCNT3, GRHL2, ITGB4, MANSC1, MCF2L, OVOL1,
PARD6B, PLS1, PPL, QKI, RAB32, RAB8B,
SACS, SLC20A1, TC2N, VIM;
miR-96: CDH1, CEP170, DSP, MAL2, PARD6B,
RHOD, SLC20A1, TUBA1A, VIM;
C4N65 miR-200b: VIPR1; miR-7: RABGAP1L
C5N65 miR-106b: TBC1D30; miR-18a: SLC12A2;
miR-30e: MOSC1, SLC12A2, TACSTD2;
miR-96: EFNA1, ERBB3, PRPS1, TSKU;
miRNAs are highlighted in bold-face texts
Functional enrichment analysis of the COREs
A CORE consists of a group of miRNAs and a group
of mRNAs, in which the individual interactions between
miRNAs and mRNAs play a vital role. To demonstrate
the effectiveness of DICORE, we identified the interac-
tions in the obtained COREs and compared them with
the experimentally confirmed interactions found in the
‘ground-truth’ databases. The confirmed interactions of
the top COREs identified from the NCI60 dataset for η =
0.65 are summarized in Table 4. The confirmed interac-
tions for the miRNAs in the miR-200 family included in
the top CORE ‘C1N65’ are illustrated in Fig. 2 using an
example CORE, where red nodes are miRNAs and green
nodes are experimentally confirmed target mRNAs. The
higher number of confirmed interactions demonstrated
the effectiveness of DICORE.
We got similar higher experimentally confirmed inter-
actions for top COREs identified from BR and MCC
datasets. The experimentally confirmed interactions for
top COREs identified from the three datasets are listed in
Additional file 3.
Pathway analysis of the COREs
A biological pathway is a group of genes that partici-
pate in a particular biological process to perform certain
functionality in a cell. To find the controlling factors of a
disease, it is meaningful to study the genes by considering
their pathway information.
We used the GeneCodis [39] online tool at [40] to
conduct pathway enrichment analysis of the COREs
with the focus on significant Kyoto Encyclopedia of
Genes and Genomes (KEGG) [41] pathways (adjusted
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Fig. 2 Confirmed interactions for miRNAs of themiR-200 family included in the top CORE ‘C1N65’ obtained from the NCI60. Red nodes are miRNAs,
and green nodes are experimentally confirmed target mRNAs
p-value < 0.05). We selected the top COREs ‘C1N60’,
‘C1B60’, and ‘C1M45’ discovered from the NCI60, BR, and
MCC datasets, respectively for the analysis, and the top 7
enrichment KEGG pathways annotated with the COREs
are listed respectively in Tables 5, 6 and 7 with their
p-values, where the p-values are adjusted by Benjamini-
Hochberg (BH) method. As shown in the tables, all the
Table 5 Top 7 enrichment KEGG pathways for CORE ‘C1N60’
from the NCI60 for η = 0.60
No KEGG Pathways p-value





3 Glutathione metabolism 3.40E–03
4 Leukocyte transendothelial migration 4.84E–03
5 Axon guidance 8.35E–03
6 Pathways in cancer 1.01E–02
7 Endocytosis 1.44E–02
COREs are significantly associated with the KEGG path-
way: Pathways in cancer. Since the three datasets are all
cancer datasets, the results demonstrate that the identi-
fied COREs are closely related to the biological conditions
of their respective datasets.
Again, we used GeneGo Metacore [42] from GeneGo
Inc. to identify the pathways previously discovered in the
literature that involve the mRNAs in the identified top
Table 6 Top 7 enrichment KEGG pathways for CORE ‘C1B60’
from the BR for η = 0.60
No KEGG Pathways p-value
1 Inositol phosphate metabolism 2.44E–02
2 Complement and coagulation cascades 3.01E–02
3 Regulation of actin cytoskeleton 3.42E–02
4 Phosphatidylinositol signaling system 3.59E–02
5 Pathways in cancer 4.05E–02
6 ECM-receptor interaction 4.44E–02
7 Prostate cancer 4.59E–02
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Table 7 Top 7 enrichment KEGG pathways for CORE ‘C1M45’
from the MCC for η = 0.45
No KEGG Pathways p-value
1 Vascular smooth muscle contraction 3.85E–08
2 Oocyte meiosis 6.07E–04
3 Complement and coagulation cascades 2.37E–03
4 Adherens junction 2.41E–03
5 Long-term depression 2.52E–03
6 Pathways in cancer 3.05E–03
7 Tight junction 4.46E–03
COREs. Table 8 shows the first 10 pathways as well as
some other related pathways identified for another top
CORE ‘C1N65’ from the NCI60 dataset. It confirms that
‘C1N65’ is highly relevant to the biological condition of
the dataset. For instance, pathways number 1, 8, 11, 14
and 20 are direct pathways of the development of EMT,
and others are important pathways involved in the process
of EMT. Moreover, pathway number 1 includes total 12
members, of which 7 were identified in ‘C1N65’.
The pathway enrichment analysis has clearly justified
the use of CCA in ranking the COREs, as the top ranked
COREs show higher biological significance, and represent
the given datasets. The detailed information of significant
Table 8 GeneGo mapped pathways for CORE ‘C1N65’ from the
NCI60 for η = 0.65
No Pathway maps p-value
1 Development_miRNA-dependent inhibition
of EMT 3.38E–12
2 Cytoskeleton remodelling_Keratin filaments 2.41E–11
3 Cell adhesion_Endothelial cell contacts by
junctional mechanisms 1.03E–07
4 Cell adhesion_Tight junctions 8.05E–07
5 Cell adhesion_Gap junctions 1.54E–04
6 Development_Neural stem cell lineage
commitment (schema) 3.92E–04
7 Cell cycle_Role of 14–3–3 proteins in cell
cycle regulation 1.03E–03
8 Hypoxia–induced EMT in cancer and fibrosis 2.90E–03
9 LRRK2 in neurons in Parkinson’s disease 3.39E–03
10 G–protein signaling_RhoA regulation
pathway 3.69E–03
11 Development_TGF–β–dependent induction
of EMT via SMADs 4.01E–03
14 Development_TGF–β–dependent induction
of EMT via MAPK 9.18E–03
20 Development_Regulation of EMT 2.11E–02
pathways identified from the three datasets is summarized
in Additional file 4.
Implication of the COREs in cancer
Since all of the input datasets included the expression
profiles of miRNAs and genes associated with cancer sam-
ples, it is expected that the COREs identified from those
datasets are to be related to cancer. To verify this, we
used a cancer miRNA benchmark dataset of 147 miRNAs
from a review article of [43]. Each of these miRNAs was
reported in the literature to be dysregulated in one or
more cancers.
The NCI60 dataset has 14 miRNAs from the bench-
mark, and except for miR-205, rest 13 are included in the
top COREs. Both the top COREs ‘C1N60’ and ‘C1N65’
from the NCI60 dataset included 9 of the 14 miRNAs
(namely miR-141, miR-148b, miR-200a, miR-200b, miR-
200c,miR-203,miR-301a,miR-32,miR-7), which are asso-
ciated with different cancers like Glioblastoma, Prostate,
Lung, Bladder, Colon, Breast, Esophageal, Colorectal,
Hepatocarcinoma, Ovarian, squamous cell carcinoma of
tongue (SCCT), and Pancreatic.
Again, among these 147 miRNAs, 34 miRNAs are rele-
vant to breast cancer. The BR dataset has 7 miRNAs out
of these 34, of which 4 are identified in the top COREs.
On the other hand, the MCC dataset has 49 miRNAs
out of the benchmark 147 miRNAs. The only CORE for
η = 0.60 included 9 miRNAs, of which 8 are from
the benchmark. These miRNAs are involved in verified
association with breast cancer (let-7d, miR-98, miR-101),
ovarian cancer (let-7c, let-7d, miR-100, miR-126, miR-
99a), prostate cancer (let-7c), Burkitt Lymphoma can-
cer (let-7c), pancreatic cancer (let-7d, miR-100), blad-
der cancer (miR-100, miR-195, miR-99a), SCCT can-
cer (miR-100, miR-195, miR-99a), lung cancer (miR-101,
miR-126), cervical cancer (miR-126), colon cancer (miR-
126), and hepatocarcinoma (miR-126) [43]. It is inter-
esting to note that one of the important parts of the
COREs identified fromMCC, i.e. the let-7 family has spe-
cial characteristics and mechanisms of tumor suppressor
activity [44, 45].
Targets prediction for miRNAs of the COREs
In this section, we report a set of novel miRNA-mRNA
interactions for further experiments. These miRNA-
mRNA interactions identified by DICORE are the pre-
dicted targets of conserved miRNA families in TargetScan
v6.2 [4, 46]. Fig 3 visualizes the predicted interactions in
a model interaction representation of the CORE ‘C1N65’,
where red nodes are miRNAs, yellow nodes are conserved
target mRNAs, and white nodes are poorly conserved tar-
get mRNAs. Predicted (conserved) interactions for top
COREs from the three databases are given in Additional
file 5.
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Fig. 3 Predicted interactions for miRNAs included in the top CORE ‘C1N65’ obtained from the NCI60. Red nodes are miRNAs, yellow and white
nodes are predicted (conserved) targets and poorly conserved targets of conserved miRNA families, respectively. Solid lines and dashed lines are
used to represent links between miRNAs and their conserved targets and poorly conserved targets, respectively. The interactions are predicted by
both DICORE and TargetScan
Comparison with other methods
We summarize here the comparison study of the result
of DICORE with the results of a few recent methods
Mirsynergy [27], SNMNMF [25], and PIMiM [47] reported
in [27]. We obtained the same ovarian cancer (OVC)
dataset processed in [25]. The original miRNA and gene
expression profiles for 385 ovarian cancer samples were
downloaded from [48]. The expression dataset contains
measurements of 559 miRNAs and 12456 mRNAs.
In case of performing a comparison study, our initial
intention was to compare the result of DICORE with the
results of two other methods, Mirsynergy [27] and SNM-
NMF [25] by applying them to the three cancer datasets
(NCI60, BR and MCC) used for validating DICORE.
However, both Mirsynergy and SNMNMF require as
their input the gene-gene interactions (GGIs) derived
from protein-protein interactions and transcription fac-
tor binding sites, which, according to [25] and [27], are
to be obtained from the two datasets, BioGrid [49] and
TRANSFAC [50]. Unfortunately, we could only man-
age to get the GGIs associated with the three cancer
datasets from BioGrid. As a consequence, the results
we obtained from Mirsynergy using these three cancer
datasets were not good. Therefore to make a fair com-
parison with the two methods, we apply our method
to the dataset (the OVC dataset) on which Mirsynergy
and SNMNMF have had their results reported in the
literature.
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Similar to the setting used in [27], we used the absolute
values of only negative interaction weights ofW and same
pair of values for the density thresholds, and set 2 for the
penalty value in calculating cohesiveness scores. In addi-
tion, we set 2 = (θm, θg) = 2 for both groups of miRNAs
and mRNAs due to the requirement for calculating CCA,
as CCA can not be applied on groups having less than 2
components.
Table 9 shows a summary of the performance of the four
methods. DICORE identified 56 modules with an aver-
age of 8.3 miRNAs and 43.83 mRNAs per module for
η = 0.35. The average strength of collective relationships
is 0.61 in terms of canonical correlation among the groups.
Furthermore, for η = 0.30,DICORE got 102modules with
11.23 miRNAs and 73.22 mRNAs per module, and having
average strength of 0.60. The average number of mRNAs
identified by Mirsynergy is too small compared to other
methods. However, average number of mRNAs identified
by DICORE is reasonable.
We report here two interesting modules. Firstly, the
module or CORE ‘C9O35’ consists of 4 miRNAs, namely
miR-29c*, miR-29a, miR-29b, and miR-29c from the same
miR-29 family. The human miR-29 family of miRNAs is
known to be associated with ovarian cancer [43, 51]. The
pathway analysis of this module also shows association
with cancer (see Table 10).
The module or CORE ‘C17O35’ included 16 miR-
NAs and 74 mRNAs. The module has miRNAs, namely
miR-17, miR-19b-1*, miR-19b, miR-19a, miR-18b, miR-
18a, miR-20a*, miR-20a, miR-20b from the polycistronic
miRNA cluster miR-17-92, located in chromosome 13.
They are considered to act as a tumor suppressor for ovar-
ian cancer in some circumstances [52]. Furthermore, the
pathway analysis of this module also illustrates association
with cancer (see Table 11).
The final module structure of Mirsynergy is heavily
depended on the initial clustering of miRNAs and the
prior knowledge of gene-gene interactions. If Mirsynergy
gets c clusters of miRNAs in the first stage, finally it will
produce at most c miRNA regulatory modules. On con-
trary, DICORE separately performs clustering of miRNAs
and mRNAs based on their functional interactions with
mRNAs and miRNAs, respectively. This allows two dis-
tinct groups of mRNAs functioning differently to be part
Table 9 Performance of DICORE,Mirsynergy, SNMNMF, and PIMiM
Method #C miR mR
DICORE 56 8.30 43.83
Mirsynergy 84 4.76 7.57
SNMNMF 49 4.12 81.37
PIMiM 40 4.70 67.80
Table 10 Top enrichment KEGG pathways for ‘C9O35’ from the
OVC for η = 0.35
No KEGG Pathways p-value
1 Basal cell carcinoma 3.85E–08
2 Arginine and proline metabolism 0.0298836
3 Glutathione metabolism 0.0398112
4 Pathways in cancer 0.0426415
5 Cell cycle 0.0495754
of different modules despite the fact that they are interact-
ing with the same group of miRNAs. Furthermore, it also
allows a group of miRNAs to interact with more than one
group of miRNAs, which is common in biological sense.
Related works
Several computational approaches had been proposed to
discover MMRMs. The concept of MMRMs was intro-
duced by [18] to denote groups of co-expressed miR-
NAs and their targets mRNAs. They drew a similarity
between predicting MMRMs and mining frequent item-
set by mapping the set of miRNAs and the set of target
mRNAs to a frequent itemset and its cover, respectively.
They proposed a prediction method adopting bipartite
graphs to model binding structures of the miRNAs and
mRNAs at the sequence level. However, prediction based
on sequence may not be sufficient to correctly predict the
complex interactions.
Improved versions of this method had been proposed
which also take into account coherent expression patterns
between miRNAs and mRNAs, or the (anti)-correlations
measured between each pair of miRNAs and mRNAs
[19, 21, 26]. Joung et al. [21] integrated expression pro-
files of miRNAs and mRNAs with sequence information
by using a biclustering approach. The approach reduced
false discovery rate significantly. A rule based method
was utilized by Tran et al. [19] based on the assump-
tion that miRNAs and mRNAs of a module have similar
expression patterns. However, these existing methods for
discovering MMRMs suffered from several limitations.
For example, Peng et al. [26] proposed a sequential inte-
grative method based on enumerating maximal bicliques
in a combined miRNA-gene network. Their method was
sensitive to noise in the data, and produced too many
star structures (one miRNA, many genes) which were not
usable to explore miRNA combinatorial regulation.
Table 11 Top enrichment KEGG pathways for ‘C17O35’ from the
OVC for η = 0.35
No KEGG Pathways p-value
1 Pathways in cancer 0.00679353
2 MAPK signaling pathway 0.0136845
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The functional MMRMs (FMMRMs) are associated
with MMRMs with specific biological conditions. For
FMMRMs discovery, [22] and [20] proposed different
methods at around the same time. Joung and Fei [22] pro-
posed an unsupervised method which applied the author-
topic model [53, 54] in bioinformatics. The method
used the expression profiles of miRNAs and the puta-
tive miRNA target information, without considering the
expression profiles of miRNAs. As the miRNA target
information is predicted at the sequence level, it encoun-
tered similar difficulty of [18] in explaining regulation
pattern of miRNAs in their target genes in the identified
modules. On the other hand, Liu et al. [20] proposed a
supervised method which utilized association rule mining
method by associating the reverse expression patterns of
miRNAs and genes with biological conditions. However,
they only considered down-regulation patterns.
In order to discover FMMRMs, Liu et al. [23] applied
another probabilistic graphical model, correspondence
Latent Dirichlet Allocation (Corr-LDA) [55], that had
been applied to automatic image annotation with cap-
tion words. By associating topics to functional modules,
images to miRNAs, and words to mRNAs, respectively,
the method was applied to a mouse model dataset for
human breast cancer research. The method simultane-
ously identified FMMRMs using the expression profiles
of both miRNAs and genes, with or without using target
relationships between miRNAs and mRNAs. The Corr-
LDA was extended and applied to identify functional
regulatory module, and each module corresponds to a
particular biological function. In the model, each func-
tion was represented as a latent topic, and the numeric
values of expression data were converted to the counts
of expression events, similar to the counts of words in
a documents. Another similar semi-supervised method
based on a probabilistic model which is closely associated
with the Latent Dirichlet Allocation [56] was proposed
in [24]. The idea of extracting topics with caption words
to FMMRMs discovery by mapping topics to functional
modules, documents to samples, and words to mRNAs,
respectively.
The main drawback of these methods is that they
did not consider the collective relationships in identi-
fying the modules, which result in regulatory modules
that may not quite correct modeling of the real biolog-
ical systems. Recently Karim et al. [28] came up with
the idea of collective group relationships, and proposed
a method to explore miRNA-mRNA regulatory relation-
ships. They integrated two complementary approaches
associated with relationships of complex systems, namely
graphmining and CCA to discover collective relationships
with both quantitative and qualitative information. How-
ever, the proposed method considered unweighted graph,
which are prone to make computational inaccuracy due to
the approximation of many interaction weights to either 1
(interaction) or 0 (no interaction). Recently Li et al. [27]
proposed a clustering algorithm,Mirsynergy to detect syn-
ergistic miRNA regulatory modules. They used mRNA
and miRNA expression profiles, target site information
and gene-gene interactions for ovarian, breast, and thy-
roid cancers from TCGA [57] and obtained significantly
higher enrichment than existing methods. However, it
partially used collective relationships in stage 1, and but
in stage 2 depended on the prior knowledge of confirmed
gene-gene interactions.
This paper presents a novel method that discover
MMRMs by considering the collective relationships as the
driving force in identifying the miRNA-mRNA regula-
tory relationships. Furthermore, it uses the idea of ranking
the identified modules by the quantitative measure of the
strength of the collective relationships between the groups
in group pairs.
Conclusion
In this paper, we have used the notation of CORE, and
proposed a computational framework DICORE to dis-
cover MMRMs. The central idea of DICORE is to con-
sider the collective group relationship, and discover both
the groups and collective relationships simultaneously.
We have applied a greedy-based overlapping clustering
approach adapted from ClusterONE [29] to group
miRNAs and mRNAs separately based on their collec-
tive interactions with mRNAs and miRNAs respectively,
and integrate CCA in order to enrich the identification of
groups with both structural link information and strength
of collective relationships. We have experimented on
three real-world biological datasets. The experimental
results have demonstrated that the proposed method
DICORE is able to reveal correct group information with
structural link information and the strength of collective
relationships, and provide useful insights into the struc-
ture and functionality of the miRNA-mRNA regulatory
relationships in MMRMs.
The proposed framework has also opened a few inter-
esting research windows for further investigation. Instead
of using Pearson correlation coefficient to calculate the
interaction weights matrix, other approaches including
statistical methods like maximal information coefficient
[58], regression techniques like Lasso [59], causal infer-
encemethod like IDA [31] can be applied. Considering the
context of the datasets, any of the individual methods or
an ensemble method [31] can be tested and reported. Fur-
thermore, the strength of the collective interactions can be
determined by applying other similar mathematical mod-
els to capture all possible association between two sets
of variables. Another interesting future work will be to
apply the framework to discover MMRMs from datasets
obtained under different biological conditions.
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